Sanofi SNY

$ 48.21 0.48%

Annual report 2023
added 11-16-2024

Sanofi Balance Sheet 2011-2024 | SNY

Annual Balance Sheet Sanofi

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	6.06 B	11 B	17.7 B	5.29 B	8.31 B	7.41 B	7.47 B	6.33 B	8.15 B	11.3 B
Long Term Debt	-	-	-	19.7 B	20.1 B	22 B	14.3 B	16.8 B	13.1 B	13.3 B	10.4 B	10.7 B	12.5 B
Long Term Debt Current	275 M	277 M	269 M	232 M	261 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	32.1 B	33.2 B	35 B	26.1 B	29.3 B	26.3 B	28.1 B	25.1 B	29 B	30.2 B
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	51.4 B	53.6 B	52.4 B	41.6 B	46.9 B	44.1 B	41.1 B	39.1 B	42.9 B	43.8 B
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	126 B	127 B	120 B	114 B	113 B	111 B	99.8 B	105 B	102 B	97.4 B	96.1 B	100 B	100 B
Cash and Cash Equivalents	8.71 B	12.7 B	10.1 B	13.9 B	9.43 B	6.92 B	10.3 B	10.3 B	9.15 B	-	-	-	-
Book Value	-	-	120 B	63 B	59 B	59 B	58.2 B	57.7 B	58.2 B	56.3 B	57 B	57.5 B	56.4 B
Total Shareholders Equity	-	-	-	63.1 B	59.1 B	59 B	58.2 B	57.7 B	58.2 B	-	-	-	-

All numbers in EUR currency

Quarterly Balance Sheet Sanofi

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	1.84 B	-	1.24 B	-	931 M	-	947 M	-	987 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	29.9 B	-	29.8 B	-	31.9 B	-	33.5 B	-	33 B	-	-	-	35 B	-	-	-	26.1 B	-	-	-	29.3 B	-	-	-	26.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	-	-	120 B	-	112 B	-	114 B	-	116 B	-	113 B	-	-	-	111 B	-	-	-	99.8 B	-	-	-	105 B	-	-	-	102 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	-	10.1 B	-	9.72 B	-	13.9 B	-	16 B	-	9.43 B	-	6.74 B	-	6.92 B	-	-	-	10.3 B	-	-	-	10.3 B	-	-	-	9.15 B	-	-	-	7.34 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	-	-	120 B	-	112 B	-	114 B	-	116 B	-	113 B	-	-	-	111 B	-	-	-	99.8 B	-	-	-	105 B	-	-	-	102 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	-	-	69 B	-	63.4 B	-	63.3 B	-	63.5 B	-	59.2 B	-	56.5 B	-	59 B	-	-	-	58.2 B	-	-	-	57.7 B	-	-	-	58.2 B	-	-	-	56.3 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency